Associations of diabetes, prediabetes and diabetes duration with the risk of chronic obstructive pulmonary disease: A prospective UK Biobank study
- PMID: 37248816
- DOI: 10.1111/dom.15142
Associations of diabetes, prediabetes and diabetes duration with the risk of chronic obstructive pulmonary disease: A prospective UK Biobank study
Abstract
Aim: To investigate the associations of diabetes, prediabetes and diabetes duration with chronic obstructive pulmonary disease (COPD) risk and survival in the UK Biobank.
Materials and methods: We conducted a prospective analysis among 452 680 participants without COPD at baseline using UK Biobank data. Multivariable-adjusted hazard ratios (HRs) and 95% confidence intervals (CIs) were estimated from Cox regression models. The dose-response relationship was explored using restricted cubic splines. A separate survival analysis was conducted for 12 595 patients with incident COPD.
Results: Over a median follow-up of 12.3 years, 12 595 cases of COPD were documented. Compared with the reference group, those with prediabetes and diabetes were associated with an 18% (HR 1.18 [95% CI: 1.13-1.24]) and 35% (HR 1.35 [95% CI: 1.24-1.47]) higher risk of COPD, respectively. Diabetes duration was associated with COPD risk, with multivariable HRs (95% CIs) of 1.23 (1.05-1.44), 1.20 (1.04-1.39) and 1.18 (1.01-1.37) for diabetes duration of 7 years or longer, 3 to less than 7 years, and 1 to less than 3 years versus less than 1 year, respectively. Dose-response analysis revealed a non-linear relationship between diabetes duration and COPD risk. Regarding COPD survival, COPD patients with prediabetes and diabetes had a 9% (HR 1.09 [95% CI: 1.00-1.19]) and 21% (HR 1.21 [95% CI: 1.05-1.41]) higher risk of overall death, respectively. Compared with the cases with a diabetes duration of less than 1 year, those with a diabetes duration of 7 years or longer were associated with a 46% higher risk of overall death (HR 1.46 [95% CI: 1.11-1.92]).
Conclusions: Our findings indicate that diabetes, prediabetes and a longer diabetes duration are associated with a higher risk of and worse survival for COPD. Future studies are warranted to determine the optimal way of diabetes control that might reduce COPD risk.
Keywords: chronic obstructive pulmonary disease; diabetes; diabetes duration; prediabetes; prospective cohort study.
© 2023 The Authors. Diabetes, Obesity and Metabolism published by John Wiley & Sons Ltd.
Similar articles
-
Association between glycated haemoglobin and the risk of chronic obstructive pulmonary disease: A prospective cohort study in UK biobank.Diabetes Obes Metab. 2023 Dec;25(12):3599-3610. doi: 10.1111/dom.15255. Epub 2023 Aug 29. Diabetes Obes Metab. 2023. PMID: 37643990
-
Association of Serum Calcium with the Risk of Chronic Obstructive Pulmonary Disease: A Prospective Study from UK Biobank.Nutrients. 2023 Aug 3;15(15):3439. doi: 10.3390/nu15153439. Nutrients. 2023. PMID: 37571375 Free PMC article.
-
Associations Between Frailty and the Increased Risk of Adverse Outcomes Among 38,950 UK Biobank Participants With Prediabetes: Prospective Cohort Study.JMIR Public Health Surveill. 2023 May 18;9:e45502. doi: 10.2196/45502. JMIR Public Health Surveill. 2023. PMID: 37200070 Free PMC article.
-
Vitamin D status and chronic obstructive pulmonary disease risk: a prospective UK Biobank study.BMJ Open Respir Res. 2023 Jun;10(1):e001684. doi: 10.1136/bmjresp-2023-001684. BMJ Open Respir Res. 2023. PMID: 37353234 Free PMC article.
-
Association between prediabetes and breast cancer: a comprehensive meta-analysis.Breast Cancer Res Treat. 2024 Feb;204(1):1-13. doi: 10.1007/s10549-023-07181-x. Epub 2023 Dec 7. Breast Cancer Res Treat. 2024. PMID: 38060076 Review.
Cited by
-
Associations between kidney function with all-cause and cause-specific mortality in type 2 diabetes mellitus patients: a prospective cohort study in China.J Health Popul Nutr. 2025 Mar 13;44(1):77. doi: 10.1186/s41043-025-00809-2. J Health Popul Nutr. 2025. PMID: 40083037 Free PMC article.
-
Comprehensive bioinformatics analysis identifies metabolic and immune-related diagnostic biomarkers shared between diabetes and COPD using multi-omics and machine learning.Front Endocrinol (Lausanne). 2025 Jan 8;15:1475958. doi: 10.3389/fendo.2024.1475958. eCollection 2024. Front Endocrinol (Lausanne). 2025. PMID: 39845878 Free PMC article.
-
Evaluating the impact of type 2 diabetes mellitus on pulmonary vascular function and the development of pulmonary fibrosis.Front Endocrinol (Lausanne). 2024 Jul 10;15:1431405. doi: 10.3389/fendo.2024.1431405. eCollection 2024. Front Endocrinol (Lausanne). 2024. PMID: 39050565 Free PMC article. Review.
-
Adverse Outcomes Associated With Inhaled Corticosteroid Use in Individuals With Chronic Obstructive Pulmonary Disease.Ann Fam Med. 2025 Mar 24;23(2):127-135. doi: 10.1370/afm.240030. Ann Fam Med. 2025. PMID: 40127974 Free PMC article.
-
Relationship between cardiovascular health and COPD andits impact on all-cause mortality in patients with COPD: analyses of NHANES 2005-2018.BMC Pulm Med. 2025 Aug 19;25(1):397. doi: 10.1186/s12890-025-03783-x. BMC Pulm Med. 2025. PMID: 40830939 Free PMC article.
References
REFERENCES
-
- Safiri S, Carson-Chahhoud K, Noori M, et al. Burden of chronic obstructive pulmonary disease and its attributable risk factors in 204 countries and territories, 1990-2019: results from the global burden of disease study 2019. BMJ. 2022;378:e069679.
-
- Donath MY, Dinarello CA, Mandrup-Poulsen T. Targeting innate immune mediators in type 1 and type 2 diabetes. Nat Rev Immunol. 2019;19:734-746.
-
- Glaser S, Kruger S, Merkel M, et al. Chronic obstructive pulmonary disease and diabetes mellitus: a systematic review of the literature. Respiration. 2015;89:253-264.
-
- Ho TW, Huang CT, Tsai YJ, Lien ASY, Lai F, Yu CJ. Metformin use mitigates the adverse prognostic effect of diabetes mellitus in chronic obstructive pulmonary disease. Respir Res. 2019;20:69.
-
- Ho TW, Huang CT, Ruan SY, Tsai YJ, Lai F, Yu CJ. Diabetes mellitus in patients with chronic obstructive pulmonary disease-the impact on mortality. PLoS One. 2017;12:e0175794.
MeSH terms
LinkOut - more resources
Full Text Sources
Medical